Biomarkers for Serious Bacterial Infections in Febrile Children

Luca Bernardi,Gianluca Bossù,Giulia Dal Canto,Giuliana Giannì,Susanna Esposito
DOI: https://doi.org/10.3390/biom14010097
IF: 6.064
2024-01-13
Biomolecules
Abstract:Febrile infections in children are a common cause of presentation to the emergency department (ED). While viral infections are usually self-limiting, sometimes bacterial illnesses may lead to sepsis and severe complications. Inflammatory biomarkers such as C reactive protein (CRP) and procalcitonin are usually the first blood exams performed in the ED to differentiate bacterial and viral infections; nowadays, a better understanding of immunochemical pathways has led to the discovery of new and more specific biomarkers that could play a role in the emergency setting. The aim of this narrative review is to provide the most recent evidence on biomarkers and predictor models, combining them for serious bacterial infection (SBI) diagnosis in febrile children. Literature analysis shows that inflammatory response is a complex mechanism in which many biochemical and immunological factors contribute to the host response in SBI. CRP and procalcitonin still represent the most used biomarkers in the pediatric ED for the diagnosis of SBI. Their sensibility and sensitivity increase when combined, and for this reason, it is reasonable to take them both into consideration in the evaluation of febrile children. The potential of machine learning tools, which represent a real novelty in medical practice, in conjunction with routine clinical and biological information, may improve the accuracy of diagnosis and target therapeutic options in SBI. However, studies on this matter are not yet validated in younger populations, making their relevance in pediatric precision medicine still uncertain. More data from further research are needed to improve clinical practice and decision making using these new technologies.
biochemistry & molecular biology
What problem does this paper attempt to address?
The paper attempts to address the issue of how to effectively diagnose serious bacterial infections (SBI) in febrile children. Specifically, it explores the current biomarkers and their predictive models used to distinguish between bacterial and viral infections, and evaluates the application value of these biomarkers in the pediatric emergency department (ED). Additionally, the paper discusses the potential of machine learning tools combined with routine clinical and biological information to improve the accuracy of SBI diagnosis and guide treatment choices. The paper points out that although C-reactive protein (CRP) and procalcitonin (PCT) are the most commonly used inflammatory biomarkers, their sensitivity and specificity can be improved through combined use. Furthermore, the paper explores other emerging biomarkers, such as cytokines (e.g., IL-2, IL-6, IL-10, IL-27), chemokines (e.g., TRAIL, IP-10), and cell adhesion molecules (e.g., presepsin, sTREM-1) in the early diagnosis of SBI. These new biomarkers and combination models may help in the earlier identification of SBI, reduce inappropriate use of antibiotics, and improve patient outcomes. In summary, the paper aims to provide pediatricians with the latest knowledge on the diagnosis and management of SBI by reviewing the latest research evidence, particularly on how to utilize biomarkers and machine learning technologies to enhance diagnostic accuracy and treatment effectiveness.